Diao Ping, Han Chenglong, Li Xiaoxue, Yang Yi, Jiang Xian
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.
Clin Cosmet Investig Dermatol. 2023 Apr 27;16:1135-1144. doi: 10.2147/CCID.S401447. eCollection 2023.
Port wine stain (PWS) is a congenital and progressive capillary malformation characterized by structural abnormalities of intradermal capillaries and postcapillary venules. The visible manifestation is often considered a disfigurement and the accompanying social stigma often causes serious emotional and physical impact. Hematoporphyrin monomethyl ether (HMME) is a newly authorized photosensitizer for treating PWS in China. Hematoporphyrin monomethyl ether photodynamic therapy (HMME-PDT) has successfully treated thousands of Chinese patients with PWS since 2017, and HMME-PDT may be one of the most promising strategies for the treatment of PWS. However, there are few reviews published about the clinical use of HMME-PDT. So in this article, we want to briefly review the mechanism, efficacy evaluation, effectiveness and influencing factors, and the common postoperative reactions and treatment suggestions of HMME-PDT in the treatment of PWS.
鲜红斑痣(PWS)是一种先天性、进行性的毛细血管畸形,其特征为真皮内毛细血管和毛细血管后微静脉的结构异常。这种可见的表现通常被视为毁容,随之而来的社会污名往往会造成严重的情感和身体影响。血卟啉单甲醚(HMME)是中国新批准用于治疗PWS的一种光敏剂。自2017年以来,血卟啉单甲醚光动力疗法(HMME-PDT)已成功治疗了数千名中国PWS患者,HMME-PDT可能是治疗PWS最有前景的策略之一。然而,关于HMME-PDT临床应用的综述发表较少。因此,在本文中,我们想简要回顾一下HMME-PDT治疗PWS的机制、疗效评估、有效性及影响因素,以及常见的术后反应和治疗建议。